Literature DB >> 21720744

Phenotypic and genetic characterization of adult T-cell acute lymphoblastic leukemia with del(9)(q34);SET-NUP214 rearrangement.

Hyojin Chae1, Jihyang Lim, Myungshin Kim, Joonhong Park, Yonggoo Kim, Kyungja Han, Seok Lee, Woo Sung Min.   

Abstract

SET-NUP214 rearrangement is a recently recognized recurrent chromosomal translocation mostly observed in T-ALL. In order to characterize this rare entity, we performed phenotypic and genetic characterization of SET-NUP214 rearrangement through an investigation of a series of 40 consecutive samples of adult T-ALL that was selected among 229 adult ALL cases during 4 years in a single institution. Four cases (10%) of SET-NUP214 translocation were identified in our study. In all cases, diagnosis of T-ALL was established according to the World Health Organization (WHO) classification, and clonal TCR rearrangements were found. The immunophenotypic markers were indicative of the precursor nature of T lymphoblasts, and they expressed one or both of the myeloid-associated antigens (CD13, CD33). Conventional cytogenetic analysis revealed complex chromosomal aberrations in all four SET-NUP214 rearranged cases and del(12)(p13)/ETV6 was frequently involved. Array-CGH demonstrated additional genomic imbalances in addition to deletion 9q34. The genomic breakpoint sequencing identified breakpoints at SET intron 7 and NUP214 intron 17, and random nucleotide addition was found in two cases at the site of rearrangement. Our independently derived data set from a single institution confirms previous findings of SET-NUP214 rearrangement, indicates the relatively high incidence of SET-NUP214 rearrangement in adult T-ALLs, and also demonstrates comprehensive clinical, phenotypic, and genetic characteristics of this entity. Also, our report on genomic breakpoints demonstrates the homogeneity in the localization of the genomic breakpoints at 9q34. Concurrent chromosomal aberrations identified in this study should provide further areas of interest in investigation of SET-NUP214-mediated leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21720744     DOI: 10.1007/s00277-011-1289-x

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  8 in total

1.  [Analysis of the clinical characteristics of 24 cases of hematological malignancies with SET-NUP214 fusion gene].

Authors:  S M Chen; W J Song; Y Z Qin; Z Wang; H Dang; Y Shi; Q He; Q Jiang; H Jiang; X J Huang; Y Y Lai
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-06-14

2.  SET-CAN Fusion Gene in Acute Leukemia and Myeloid Neoplasms: Report of Three Cases and a Literature Review.

Authors:  Heyang Zhang; Lijun Zhang; Yan Li; Hongcang Gu; Xiaoxue Wang
Journal:  Onco Targets Ther       Date:  2020-08-03       Impact factor: 4.147

3.  B-cell acute lymphoblastic leukemia associated with SET-NUP214 rearrangement: A case report and review of the literature.

Authors:  Hong-Hu Zhu; Xiao-Su Zhao; Ya-Zhen Qin; Yue-Yun Lai; Hao Jiang
Journal:  Oncol Lett       Date:  2016-02-23       Impact factor: 2.967

4.  NUP214 fusion genes in acute leukemia (Review).

Authors:  Min-Hang Zhou; Qing-Ming Yang
Journal:  Oncol Lett       Date:  2014-06-18       Impact factor: 2.967

5.  [Clinical characteristics of four SET-NUP214 positive acute leukemia patients].

Authors:  X Y Dong; Y L Li; L S Liu; W Cheng; B J Shang; L Zhang; M Y Shi; F Wang; K Sun
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-12-14

6.  Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With SET-CAN/NUP214 Fusion: Perspectives From a Case Report and Literature Review.

Authors:  Na Lin; Zhenghua Liu; Yan Li; Xiaojing Yan; Lei Wang
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

7.  Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins.

Authors:  Thomas Steimlé; Marie-Emilie Dourthe; Marion Alcantara; Aurore Touzart; Mathieu Simonin; Johanna Mondesir; Ludovic Lhermitte; Jonathan Bond; Carlos Graux; Nathalie Grardel; Jean-Michel Cayuela; Isabelle Arnoux; Virginie Gandemer; Marie Balsat; Norbert Vey; Elizabeth Macintyre; Norbert Ifrah; Hervé Dombret; Arnaud Petit; André Baruchel; Philippe Ruminy; Nicolas Boissel; Vahid Asnafi
Journal:  Blood Cancer J       Date:  2022-01-26       Impact factor: 9.812

8.  The characteristics and prognostic significance of the SET-CAN/NUP214 fusion gene in hematological malignancies: A systematic review.

Authors:  Jing Wang; Qian-Ru Zhan; Xiao-Xuan Lu; Li-Jun Zhang; Xiao-Xue Wang; He-Yang Zhang
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.